Fink Ogawa, Lisa M.Bova, Carol A2022-08-232022-08-232009-07-212018-10-24<p>Subst Use Misuse. 2009;44(7):915-33. doi: 10.1080/10826080802486897. <a href="https://doi.org/10.1080/10826080802486897">Link to article on publisher's site</a></p>1082-6084 (Linking)10.1080/1082608080248689719440928https://hdl.handle.net/20.500.14038/34563Hepatitis C virus (HCV) infection is a major source of morbidity and mortality among substance users and persons living with human immunodeficiency virus (HIV) infection. Treatment for chronic HCV infection involves complex decision-making. These decisions are even more complicated in persons with HIV and substance use related problems. A secondary analyses of qualitative data collected in the United States (2004-2005) with 31 HIV/HCV coinfected adults (48% women; mean age 44.7 years) revealed three themes related to substance use (substance use evolution, revolving door: going back out and reconstructing life) and two HCV treatment decision-making themes (HCV infection treatment issues: not a priority, fear, misinformation and get clean and try it). Study limitations and implications are discussed.en-USHealth Services AdministrationHealth Services ResearchSubstance Abuse and AddictionVirus DiseasesJournal Articlehttps://escholarship.umassmed.edu/gsn_pp/7313157084gsn_pp/73